Research Article

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes

Table 3

Univariate and multivariate analysis for prediction of visual outcomes at 12 months.

Variables at baselineBCVA scoreΔBCVA scoreBCVA ΔBCVA
Univariate analysis ( value)Multivariable analysis ( value)Univariate analysis ( value)Multivariable analysis ( value)Univariate analysis ( value)Multivariable analysis ( value)Univariate analysis ( value)Multivariable analysis ( value)

Gender0.4390.5080.9210.615
Age0.0870.0830.1770.0840.5260.0940.090
Treatment delay0.9090.6340.9890.482
Baseline BCVA<0.001<0.0010.001<0.001<0.001<0.0010.0010.001
CNV lesion subtype0.0410.0800.1210.277
CFT0.0030.5380.9270.0470.6450.576
Subfoveal hemorrhage0.5380.3401.0001.000
Subretinal fibrosis0.6030.7431.0000.481

BCVA: best-corrected visual acuity; Δ: variation; CNV: choroidal neovascularization; CFT: central foveal thickness; value was from the following: independent-samples t-test; one-way ANOVA; Kruskal-Wallis test; Pearson chi-square; binomial logistic regression; linear-by-linear association; Fisher’s exact test; variables with in univariate analysis were included in the multivariable analysis; variables with in multivariable analysis were included in the final multivariable model for predictive factors of designated outcome.